Sodium Carbonate → HCID 66990281, compound

HRID 1627233Notes

Reaction equation

HRID 1627233 reaction equation
[CH2:1]([O:3][C:4]([C:6]1[NH:15][C:9]2=[N:10][CH:11]=[C:12](Br)[CH:13]=[C:8]2[CH:7]=1)=[O:5])[CH3:2].B1(B2OC(C)(C)C(C)(C)O2)OC(C)(C)C(C)(C)O1.C1(P(C2CCCCC2)C2CCCCC2)CCCCC1.C([O-])(=O)C.[K+].[N:58]1[CH:63]=[CH:62][C:61]([CH2:64][NH:65][C:66]([C:68]2[N:69]([CH2:75][O:76][CH2:77][CH2:78][Si:79]([CH3:82])([CH3:81])[CH3:80])[C:70]([CH3:74])=[C:71](Br)[N:72]=2)=[O:67])=[CH:60][CH:59]=1.C([O-])([O-])=O.[Na+].[Na+]>O1CCOCC1.CO.ClCCl.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd]>[CH2:1]([O:3][C:4]([C:6]1[NH:15][C:9]2=[N:10][CH:11]=[C:12]([C:71]3[NH:72][C:68]([C:66](=[O:67])[NH:65][CH2:64][C:61]4[CH:62]=[CH:63][N:58]=[CH:59][CH:60]=4)=[N:69][C:70]=3[CH3:74])[CH:13]=[C:8]2[CH:7]=1)=[O:5])[CH3:2].[CH2:1]([O:3][C:4]([C:6]1[NH:15][C:9]2=[N:10][CH:11]=[C:12]([C:71]3[N:72]=[C:68]([C:66](=[O:67])[NH:65][CH2:64][C:61]4[CH:62]=[CH:63][N:58]=[CH:59][CH:60]=4)[N:69]([CH2:75][O:76][CH2:77][CH2:78][Si:79]([CH3:80])([CH3:82])[CH3:81])[C:70]=3[CH3:74])[CH:13]=[C:8]2[CH:7]=1)=[O:5])[CH3:2]

Participants

11

Conditions

Temperature
110 °C

Procedure

A mixture of 5-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid ethyl ester (143 mg, 0.53 mmol), bis(pinacolato)diboron (202 mg, 0.79 mmol), tricyclohexylphosphine (15 mg, 0.053 mmol), potassium acetate (105 mg, 1.07 mmol) and Pd(dba)2 (15 mg, 0.027 mmol) in 1,4-dioxane (5 ml) is heated to 110° C. in an oil bath for 1 hour under argon. 4-Bromo-5-methyl-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazole-2-carboxylic acid(pyridin-4-ylmethyl)-amide (225 mg, 0.53 mmol) and (Bis(di-t-butyl(4-dimethylaminophenyl)phosphine)dichloropalladium(II) (38 mg, 0.053 mmol) and aqueous Na2CO3 (2M, 1.33 ml, 2.65 mmol) are added, and the reaction mixture is heated at 110° C. for 1 hour. The mixture is cooled to room temperature, diluted with 5% methanol/dichloromethane and filtered through celite. The filtrate is evaporated in vacuo, and the crude product is purified by reverse phase HPLC to give the title compound 5-[5-Methyl-2-[(pyridin-4-ylmethyl)-carbamoyl]-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-4-yl]-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid ethyl ester as a light yellow solid 150 mg, 53%, LC/MS ESI m/z (M+H)+=535.61.

Workup

  1. temperaturethe reaction mixture is heated at 110° C. for 1 hour
  2. temperatureThe mixture is cooled to room temperature
  3. filtrationfiltered through celite
  4. customThe filtrate is evaporated in vacuo
  5. customthe crude product is purified by reverse phase HPLC

Sources & evidence

ORD record
ord-592e2c03285f4db9ba0a0123b1a379ac
Source dataset
uspto-grants-2014_07
Patent number
US08785489B2

Reaction notes

Loading…